Friday, November 13, 2020 1:34:52 PM
Financial Results for the Three Months Ended September 30, 2020 compared to September 30, 2019
Total net revenue was $4,292,000 compared to $1,600,000, representing an increase of $2,692,000, or 168%.
SteraMist® equipment-based revenues was $2,945,000 and $669,000, respectively, representing an increase of $2,276,000 or 340%
SteraMist® BIT Solution-based revenues was $732,000 and $259,000, respectively, representing an increase of $473,000 or 183%
Service-based revenue was $615,000 and $672,000, respectively, representing a decrease of $57,000 or 8%.
Domestic revenue was $3,446,000 and $1,288,000, respectively, representing an increase of $2,158,000, or 168%.
International revenue was approximately $846,000 and $312,000, respectively, representing an increase of $534,000 or 171%.
Gross margins were 66.1% compared to 71.3%. The lower gross profit is attributable to the product mix in sales.
Income from operations was $1,096,000, compared to a Loss from operations of ($188,000), representing an increase of $1,284,000.
Net Income was $1,019,000, or $0.06 on a per share basis compared to a Net loss of ($237,000), or ($0.02) on a per share basis, representing an increase of $1,256,000.
EBIDTA was $1,274,000 compared to an adjusted net loss of ($5,000). A table reconciling EBITDA to the appropriate GAAP measure is included with the Company's financial information below.
Cash provided from operations for the nine months ended September 30, 2020 and 2019 of $4,945,000, compared to cash used in operations of ($573,000), respectively.
Balance sheet highlights as of September 30, 2020 and December 31, 2019
Cash and cash equivalents of approximately $5,885,000 and $897,000, representing an increase of $4,988,000.
Working capital of $11,692,000 and ($1,266,000), representing an increase of $12,958,000.
Shareholders’ equity of $13,251,000 and $890,000, representing an increase of $12,361,000.
Current Business Highlights To Date
Revenues
Milestone reached in the third quarter of 2020 with total revenues exceeding $21 million in a calendar year.
Year over year growth in overall revenue through September 30th of $16,882,000 or 376%.
Year over year growth SteraMist® equipment revenue through September 30th of $13,165,000 or 456%.
Year over year growth SteraMist® BIT Solution revenue through September 30th of $2,931,000 or 509%.
Year over year growth in service revenue through September 30th of $786,000 or 76%.
https://www.biospace.com/article/releases/steramist-continues-to-provide-proven-regulated-disinfection-for-covid-19-and-other-pathogens/#:~:text=Coronavirus%20and%20COVID%2D19%20has,resistant%20pathogens%20known%20to%20mankind.
https://tomimist.com/
Recent TOMZ News
- TOMI Environmental Solutions to Present at the H.C. Wainwright Annual Global Investment Conference • GlobeNewswire Inc. • 09/06/2024 02:08:51 PM
- TOMI Environmental Solutions Expands Partnership With A Global Leader in Laboratory Services • GlobeNewswire Inc. • 08/22/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 08:08:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:05:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:05:36 PM
- TOMI Environmental Solutions, Inc. Reports 170% Sequential Growth in Second Quarter Revenue With Break Even EPS • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Second Quarter 2024 Financial Results on August 1, 2024 • GlobeNewswire Inc. • 07/26/2024 08:30:00 PM
- TOMI Environmental Announces Preliminary Second Quarter Revenue • GlobeNewswire Inc. • 07/25/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 12:06:10 PM
- TOMI Environmental Solutions Secures $1.2 Million Contract with Enviro-Mist Inc. Driving SteraMist Growth in the Pharmaceutical Market • GlobeNewswire Inc. • 07/24/2024 12:30:00 PM
- TOMI Environmental Solutions Supports Partners and Customers to Combat Global Avian Influenza (H5N1) Bird Flu Outbreak • GlobeNewswire Inc. • 06/13/2024 12:30:00 PM
- TOMI Environmental Solutions Secures Two New Purchase Agreements with Leading Pharmaceutical Companies • GlobeNewswire Inc. • 06/10/2024 01:00:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:03:39 PM
- TOMI Environmental Solutions, Inc. Announces Cost Reduction Efforts to Sustain Long Term Growth and Achieve Profitability • GlobeNewswire Inc. • 06/06/2024 04:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:34:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:30:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:26:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:21:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:17:15 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:04:23 PM
- TOMI Environmental Solutions, Inc. Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/15/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:01:34 PM
- TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss First Quarter 2024 Financial Results on May 15, 2024 • GlobeNewswire Inc. • 05/09/2024 10:10:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/08/2024 02:12:18 PM
- TOMI Environmental Solutions to Attend Interphex 2024 • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM